Quantcast

Latest balloon catheter Stories

2009-07-27 06:09:00

MINNEAPOLIS, July 27 /PRNewswire/ -- Lutonix, Inc., a privately held medical device start-up, today announced that patient enrollment is underway for its three simultaneous first-in-human clinical trials. The three studies are designed to test whether the proprietary Lutonix Drug Coated Balloon (DCB) Catheter is safe and effective in the treatment of vascular narrowing. The PERVIDEO I Registry The PERVIDEO I Registry is investigating the Lutonix Drug Coated Balloon Catheter for the...

2009-06-23 15:07:00

Advanced Platinum Surface Maximizes Biocompatibility and Biostabilityin a Bare-Metal Stent BURLINGTON, Mass., June 23 /PRNewswire/ -- CorNova Inc. today announced that it has received CE mark approval for its Valecor Platinum Coronary Stent System. (Logo: http://www.newscom.com/cgi-bin/prnh/20070206/CLTU213LOGO ) The Valecor Platinum is a next-generation cobalt-chromium bare-metal stent. Utilizing a novel ion-based implantation technology called Nanofusion(TM), the Valecor Platinum...

2009-06-23 07:00:00

Broad Size Matrix of XIENCE PRIME to be Launched in Europe in the Third Quarter ABBOTT PARK, Ill., June 23 /PRNewswire-FirstCall/ -- Abbott announced today that it has received CE Mark (Conformite Europeenne) for its next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease. The company plans to launch XIENCE PRIME in a broad size matrix with lengths up to 38 mm in Europe in the third quarter. "XIENCE PRIME leverages and will...

2009-05-28 09:21:00

Positive clinical data, competitor focus, and new drug-eluting technologies to drive lower extremity procedures in Europe, according to Millennium Research Group WALTHAM, Mass., May 28 /PRNewswire/ -- According to Millennium Research Group's (MRG's) European Markets for Peripheral Vascular (PV) Devices 2009 report, rapid growth in the number of endovascular procedures that treat lower extremity peripheral artery disease in Europe is being fueled by positive clinical trial results, increased...

2009-03-10 08:02:00

Latest Innovation in Balloon Technology, Designed to Optimize Treatment of Patients with Coronary Artery Disease ABBOTT PARK, Ill., March 10 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced the launch of VOYAGER(TM) NC Coronary Dilatation Catheter, a next-generation balloon dilatation catheter with high-pressure capability designed to optimize the treatment of patients with coronary artery disease (CAD) during angioplasty procedures. VOYAGER NC is now available in the United...

2009-03-03 06:00:00

BURLINGTON, Mass., Mar. 3 /PRNewswire/ -- CorNova, Inc. today announced the addition of Andrew T. Jay, D.M.D., to its board of directors. The addition increases board membership to 4. (Logo: http://www.newscom.com/cgi-bin/prnh/20070206/CLTU213LOGO ) Dr. Jay, 46, is the managing partner of the Medical Solutions Fund of Siemens Venture Capital GmbH, the venture organization for Siemens AG. Prior to joining Siemens Venture Capital, he was an Institutional Investor-ranked medical technology...

2009-02-17 06:00:00

Company Also Names Richard Sahagian as Senior Scientist BURLINGTON, Mass., Feb. 17 /PRNewswire/ -- CorNova(R), Inc. today announced the expansion of its executive team with the appointment of Robert Gallahue as chief financial officer. The company also announced the addition of Richard Sahagian as senior scientist. (Logo: http://www.newscom.com/cgi-bin/prnh/20070206/CLTU213LOGO ) The appointments reflect the evolution of the company's endovascular product line, which includes the...

2008-12-09 15:30:00

PLYMOUTH, Minn., Dec. 9 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV), a global endovascular device company, announced today that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) to market its EverCross 0.035" and NanoCross 0.014" peripheral angioplasty balloon catheters. ev3 expects to begin full commercialization of the EverCross and NanoCross peripheral balloon catheters globally in January 2009. Robert Palmisano, ev3's president and chief...

2008-10-07 12:00:53

An analysis of clinical data from 90 hospitals across the nation showed that during certain parts of the day, wait times for cardiac catheterization procedures significantly exceed the recommended standard of 90 minutes. The data analysis research was performed by VHA Inc., the national health care alliance. According to the American College of Cardiology and the American Heart Association, the benchmark door-to-balloon time -- the time between arrival at the hospital ED and having a...

2008-09-21 03:00:12

By Mularczyk, T Kostewicz, W Aim. Local intra-arterial thrombolysis is one of the methods of treatment of acute ischemia of extremities. Its aim is rapid restoration of arterial patency and the reperfusion of the ischemic extremity. It allows the identification of the cause of arterial occlusion. Identification and description of arterial wall lesions informs decisions optimizing further therapy, either surgical or endovascular. Methods. From 2003 to 2005, 17 patients with femoro- popliteal...


Latest balloon catheter Reference Libraries

Interventional Radiology
2013-03-04 16:18:42

Interventional radiology (IR) is a special sub-operation under general radiology. It is used to find, diagnose and treat a disease in almost every body system. The process of interventional radiology is very noninvasive to help with the recovery and outcome of the procedure. It utilizes x-rays, CT, ultrasound, MRI, and other modes of imaging in order to direct tools in the body as well as a variety of catheters, narrow tubes, so that incisions can be minimalized. How it is Performed...

More Articles (1 articles) »
Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related